Cargando…
Comparison of albumin-bilirubin grade versus Child-Pugh score in predicting the outcome of transarterial chemoembolization for hepatocellular carcinoma using time-dependent ROC
BACKGROUND: The Child-Pugh score has been used extensively to assess hepatic function and predict post-treatment outcomes in patients with hepatocellular carcinoma (HCC). Recently, the albumin-bilirubin (ALBI) grade has been put forward as an objective method of evaluating liver function and predict...
Autores principales: | Zhao, Shoujie, Zhang, Ting, Li, Huichen, Wang, Mengmeng, Xu, Ke, Zheng, Desha, Du, Xilin, Liu, Lei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7214909/ https://www.ncbi.nlm.nih.gov/pubmed/32411761 http://dx.doi.org/10.21037/atm.2020.02.124 |
Ejemplares similares
-
Comparison between Child-Pugh score and Albumin-Bilirubin grade in the prognosis of patients with HCC after liver resection using time-dependent ROC
por: Zhao, Shoujie, et al.
Publicado: (2020) -
Comparison between Child-Pugh Score and albumin-bilirubin grade in patients treated with the combination therapy of transarterial chemoembolization and sorafenib for hepatocellular carcinoma
por: Wang, Zhexuan, et al.
Publicado: (2020) -
Changes in prognostic factors for patients with hepatocellular carcinoma underwent transarterial chemoembolization with the transition of the time: Child-Pugh class, Albumin-Bilirubin grade, and then
por: Kawaguchi, Takumi, et al.
Publicado: (2020) -
Evaluation of Pretreatment Albumin–Bilirubin Grade as a Better Prognostic Factor Compared to Child–Pugh Classification in Patients with Hepatocellular Carcinoma Receiving Transarterial Chemoembolization Combined with Radiotherapy
por: Lee, Jason Joon Bock, et al.
Publicado: (2023) -
Prognostic value of the albumin-bilirubin grade in patients with hepatocellular carcinoma and other liver diseases
por: Feng, Dayun, et al.
Publicado: (2020)